相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。3D pancreatic carcinoma spheroids induce a matrix-rich, chemoresistant phenotype offering a better model for drug testing
Paola Longati et al.
BMC CANCER (2013)
Lysine-5 Acetylation Negatively Regulates Lactate Dehydrogenase A and Is Decreased in Pancreatic Cancer
Di Zhao et al.
CANCER CELL (2013)
Attenuation of LDHA expression in cancer cells leads to redox-dependent alterations in cytoskeletal structure and cell migration
Robert Arseneault et al.
CANCER LETTERS (2013)
Enhancement of the Antiproliferative Activity of Gemcitabine by Modulation of c-Met Pathway in Pancreatic Cancer
Amir Avan et al.
CURRENT PHARMACEUTICAL DESIGN (2013)
Hypoxia inducible factor 2 alpha inhibits hepatocellular carcinoma growth through the transcription factor dimerization partner 3/E2F transcription factor 1-dependent apoptotic pathway
Hai-Xiang Sun et al.
HEPATOLOGY (2013)
Prognostic value of CA 19-9, CEA, CRP, LDH and bilirubin levels in locally advanced and metastatic pancreatic cancer: results from a multicenter, pooled analysis of patients receiving palliative chemotherapy
Michael Haas et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2013)
Assessing the differential action on cancer cells of LDH-A inhibitors based on the N-hydroxyindole-2-carboxylate (NHI) and malonic (Mal) scaffolds
Carlotta Granchi et al.
ORGANIC & BIOMOLECULAR CHEMISTRY (2013)
Cancer Statistics, 2012
Rebecca Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2012)
Systemic treatment of advanced pancreatic cancer
Volker Heinemann et al.
CANCER TREATMENT REVIEWS (2012)
Galloflavin (CAS 568-80-9): A Novel Inhibitor of Lactate Dehydrogenase
Marcella Manerba et al.
CHEMMEDCHEM (2012)
The Pancreas Cancer Microenvironment
Christine Feig et al.
CLINICAL CANCER RESEARCH (2012)
Molecular Targets of Gemcitabine Action: Rationale for Development of Novel Drugs and Drug Combinations
Maha Elnaggar et al.
CURRENT PHARMACEUTICAL DESIGN (2012)
Molecular Mechanisms Involved in the Synergistic Interaction of the EZH2 Inhibitor 3-Deazaneplanocin A with Gemcitabine in Pancreatic Cancer Cells
Amir Avan et al.
MOLECULAR CANCER THERAPEUTICS (2012)
Hypoxia Induces EMT in Low and Highly Aggressive Pancreatic Tumor Cells but Only Cells with Cancer Stem Cell Characteristics Acquire Pronounced Migratory Potential
Alexei V. Salnikov et al.
PLOS ONE (2012)
Preclinical emergence of vandetanib as a potent antitumour agent in mesothelioma: molecular mechanisms underlying its synergistic interaction with pemetrexed and carboplatin
E. Giovannetti et al.
BRITISH JOURNAL OF CANCER (2011)
Hypoxia Predicts Aggressive Growth and Spontaneous Metastasis Formation from Orthotopically Grown Primary Xenografts of Human Pancreatic Cancer
Qing Chang et al.
CANCER RESEARCH (2011)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
N-Hydroxyindole-based inhibitors of lactate dehydrogenase against cancer cell proliferation
Carlotta Granchi et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2011)
RETENTION OF THE IN VITRO RADIOSENSITIZING POTENTIAL OF GEMCITABINE UNDER ANOXIC CONDITIONS, IN p53 WILD-TYPE AND p53-DEFICIENT NON-SMALL-CELL LUNG CARCINOMA CELLS
An Wouters et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2011)
Discovery of N-Hydroxyindole-Based Inhibitors of Human Lactate Dehydrogenase Isoform A (LDH-A) as Starvation Agents against Cancer Cells
Carlotta Granchi et al.
JOURNAL OF MEDICINAL CHEMISTRY (2011)
Proteomic Analysis of Pancreatic Ductal Adenocarcinoma Cells Reveals Metabolic Alterations
Weidong Zhou et al.
JOURNAL OF PROTEOME RESEARCH (2011)
Hypoxia Induces Tumor Aggressiveness and the Expansion of CD133-Positive Cells in a Hypoxia-Inducible Factor-1 alpha-Dependent Manner in Pancreatic Cancer Cells
Okito Hashimoto et al.
PATHOBIOLOGY (2011)
Targeting hypoxia in cancer therapy
William R. Wilson et al.
NATURE REVIEWS CANCER (2011)
Tumour necrosis is a postoperative prognostic marker for pancreatic cancer patients with a high interobserver reproducibility in histological evaluation
N. Hiraoka et al.
BRITISH JOURNAL OF CANCER (2010)
MicroRNA-21 in Pancreatic Cancer: Correlation with Clinical Outcome and Pharmacologic Aspects Underlying Its Role in the Modulation of Gemcitabine Activity
Elisa Giovannetti et al.
CANCER RESEARCH (2010)
Inhibitors of Lactate Dehydrogenase Isoforms and their Therapeutic Potentials
C. Granchi et al.
CURRENT MEDICINAL CHEMISTRY (2010)
Warburg effect in chemosensitivity: Targeting lactate dehydrogenase-A re-sensitizes Taxol-resistant cancer cells to Taxol
Ming Zhou et al.
MOLECULAR CANCER (2010)
Inhibition of lactate dehydrogenase A induces oxidative stress and inhibits tumor progression
Anne Le et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Hypoxia Induced Tumor Metabolic Switch Contributes to Pancreatic Cancer Aggressiveness
Sophie Vasseur et al.
Cancers (2010)
Effect of hypoxia on the expression of phosphoglycerate kinase and antitumor activity of troxacitabine and gemcitabine in non-small cell lung carcinoma
Wing Lam et al.
MOLECULAR CANCER THERAPEUTICS (2009)
LDH-A inhibition, a therapeutic strategy for treatment of hereditary leiomyomatosis and renal cell cancer
Han Xie et al.
MOLECULAR CANCER THERAPEUTICS (2009)
Lactate promotes glioma migration by TGF-β2-dependent regulation of matrix metalloproteinase-2
Fusun Baumann et al.
NEURO-ONCOLOGY (2009)
Lactate dehydrogenase-5 (LDH-5) expression in human gastric cancer:: Association with hypoxia-inducible factor (HIF-1α) pathway, angiogenic factors production and poor prognosis
Yanislav Kolev et al.
ANNALS OF SURGICAL ONCOLOGY (2008)
Targeting angiogenesis in pancreatic cancer: rationale and pitfalls
Chery Whipple et al.
LANGENBECKS ARCHIVES OF SURGERY (2008)
Molecular mechanisms underlying the synergistic interaction of erlotinib, an epidermal growth factor receptor tyrosine kinase inhibitor, with the multitargeted antifolate pemetrexed in non-small-cell lung cancer cells
Elisa Giovannetti et al.
MOLECULAR PHARMACOLOGY (2008)
Oxygen-dependent regulation of mitochondrial respiration by hypoxia-inducible factor 1
Gregg L. Semenza
BIOCHEMICAL JOURNAL (2007)
Regulation of tumor pH and the role of carbonic anhydrase 9
Pawel Swietach et al.
CANCER AND METASTASIS REVIEWS (2007)
Inhibitory effect of tumor cell-derived lactic acid on human T cells
Karin Fischer et al.
BLOOD (2007)
Increased expression of tissue transglutaminase in pancreatic ductal adenocarcinoma and its implications in drug resistance and metastasis
Amit Verma et al.
CANCER RESEARCH (2006)
Oxygen and glucose consumption in gastrointestinal adenocarcinomas: Correlation with markers of hypoxia, acidity and anaerobic glycolysis
Michael I. Koukourakis et al.
CANCER SCIENCE (2006)
Attenuation of LDH-A expression uncovers a link between glycolysis, mitochondrial physiology, and tumor maintenance
Valeria R. Fantin et al.
CANCER CELL (2006)
Antiangiogenic treatment with the three thrombospondin-1 type 1 repeats recombinant protein in an orthotopic human pancreatic cancer model
XF Zhang et al.
CLINICAL CANCER RESEARCH (2005)
Interaction between gemcitabine and topotecan in human non-small-cell lung cancer cells: effects on cell survival, cell cycle and pharmacogenetic profile
E Giovannetti et al.
BRITISH JOURNAL OF CANCER (2005)
Lactate dehydrogenase 5 (LDH5) relates to up-regulated hypoxia inducible factor pathway and metastasis in colorectal cancer
MI Koukourakis et al.
CLINICAL & EXPERIMENTAL METASTASIS (2005)
Hypoxia increases resistance of human pancreatic cancer cells to apoptosis induced by gemcitabine
K Yokoi et al.
CLINICAL CANCER RESEARCH (2004)
Hypoxic gene expression and metastasis
QT Le et al.
CANCER AND METASTASIS REVIEWS (2004)
Opinion - Analysis of genomic targets reveals complex functions of MYC
JH Patel et al.
NATURE REVIEWS CANCER (2004)
Why do cancers have high aerobic glycolysis?
RA Gatenby et al.
NATURE REVIEWS CANCER (2004)
Hypoxia - A key regulatory factor in tumour growth
AL Harris
NATURE REVIEWS CANCER (2002)
The multilayered postconfluent cell culture as a model for drug screening
JM Padrón et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2000)
Pancreatic tumors show high levels of hypoxia
AC Koong et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2000)